

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | vocalization behavior (GO:0071625) | 5.85392344 |
| 2 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.79218314 |
| 3 | neuron cell-cell adhesion (GO:0007158) | 5.67353244 |
| 4 | synaptic vesicle exocytosis (GO:0016079) | 5.58344929 |
| 5 | tachykinin receptor signaling pathway (GO:0007217) | 5.57958018 |
| 6 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.53081548 |
| 7 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 5.43063352 |
| 8 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.23807753 |
| 9 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.22422472 |
| 10 | glutamate secretion (GO:0014047) | 5.14994890 |
| 11 | presynaptic membrane assembly (GO:0097105) | 5.14513297 |
| 12 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.05630879 |
| 13 | presynaptic membrane organization (GO:0097090) | 4.92740962 |
| 14 | protein localization to synapse (GO:0035418) | 4.90945616 |
| 15 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.81434097 |
| 16 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.75445429 |
| 17 | DNA double-strand break processing (GO:0000729) | 4.63633661 |
| 18 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.53164056 |
| 19 | postsynaptic membrane organization (GO:0001941) | 4.50108348 |
| 20 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.48432071 |
| 21 | long-term synaptic potentiation (GO:0060291) | 4.47487436 |
| 22 | positive regulation of synapse maturation (GO:0090129) | 4.45973384 |
| 23 | locomotory exploration behavior (GO:0035641) | 4.39022375 |
| 24 | regulation of synaptic vesicle transport (GO:1902803) | 4.33999372 |
| 25 | neuron-neuron synaptic transmission (GO:0007270) | 4.32896269 |
| 26 | response to histamine (GO:0034776) | 4.27639397 |
| 27 | neurotransmitter secretion (GO:0007269) | 4.21057582 |
| 28 | glutamate receptor signaling pathway (GO:0007215) | 4.16927951 |
| 29 | synaptic transmission, glutamatergic (GO:0035249) | 4.11825539 |
| 30 | * regulation of glutamate secretion (GO:0014048) | 4.08587740 |
| 31 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.03366868 |
| 32 | righting reflex (GO:0060013) | 4.03093249 |
| 33 | neuronal action potential propagation (GO:0019227) | 4.03074623 |
| 34 | otic vesicle formation (GO:0030916) | 3.93259667 |
| 35 | synaptic vesicle maturation (GO:0016188) | 3.91938706 |
| 36 | cerebellar granule cell differentiation (GO:0021707) | 3.91116143 |
| 37 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.85184999 |
| 38 | startle response (GO:0001964) | 3.84689211 |
| 39 | positive regulation of mitochondrial fission (GO:0090141) | 3.84600539 |
| 40 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.81301943 |
| 41 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.81301943 |
| 42 | regulation of postsynaptic membrane potential (GO:0060078) | 3.79624504 |
| 43 | transferrin transport (GO:0033572) | 3.78596862 |
| 44 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.78306344 |
| 45 | regulation of synapse maturation (GO:0090128) | 3.78178189 |
| 46 | cell migration in hindbrain (GO:0021535) | 3.74922366 |
| 47 | negative regulation of appetite (GO:0032099) | 3.73863724 |
| 48 | negative regulation of response to food (GO:0032096) | 3.73863724 |
| 49 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.72516992 |
| 50 | fatty acid elongation (GO:0030497) | 3.72483980 |
| 51 | positive regulation of synapse assembly (GO:0051965) | 3.71645156 |
| 52 | behavioral response to cocaine (GO:0048148) | 3.71404849 |
| 53 | neuron recognition (GO:0008038) | 3.68813673 |
| 54 | regulation of synaptic plasticity (GO:0048167) | 3.67930315 |
| 55 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.63214150 |
| 56 | * negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.60650046 |
| 57 | exploration behavior (GO:0035640) | 3.59952988 |
| 58 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.58791799 |
| 59 | positive regulation of membrane potential (GO:0045838) | 3.54526541 |
| 60 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.53233565 |
| 61 | trivalent inorganic cation transport (GO:0072512) | 3.52456806 |
| 62 | ferric iron transport (GO:0015682) | 3.52456806 |
| 63 | serotonin metabolic process (GO:0042428) | 3.52203872 |
| 64 | neurotransmitter transport (GO:0006836) | 3.50443078 |
| 65 | urinary tract smooth muscle contraction (GO:0014848) | 3.49936029 |
| 66 | negative regulation of neurotransmitter transport (GO:0051589) | 3.47909368 |
| 67 | somite development (GO:0061053) | 3.42907044 |
| 68 | polyol transport (GO:0015791) | 3.42489787 |
| 69 | regulation of neurotransmitter secretion (GO:0046928) | 3.42414196 |
| 70 | cellular response to leptin stimulus (GO:0044320) | 3.40506377 |
| 71 | response to auditory stimulus (GO:0010996) | 3.39298679 |
| 72 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.39215795 |
| 73 | synaptic vesicle endocytosis (GO:0048488) | 3.38302019 |
| 74 | positive regulation of neurotransmitter transport (GO:0051590) | 3.35891186 |
| 75 | long-term memory (GO:0007616) | 3.35692097 |
| 76 | triglyceride catabolic process (GO:0019433) | 3.34723927 |
| 77 | regulation of vesicle fusion (GO:0031338) | 3.31479512 |
| 78 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.24532772 |
| 79 | long term synaptic depression (GO:0060292) | 3.23350601 |
| 80 | response to pheromone (GO:0019236) | 3.23047498 |
| 81 | axonal fasciculation (GO:0007413) | 3.20666399 |
| 82 | C4-dicarboxylate transport (GO:0015740) | 3.19734954 |
| 83 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.19366493 |
| 84 | regulation of female receptivity (GO:0045924) | 3.19170231 |
| 85 | paraxial mesoderm development (GO:0048339) | 3.18882825 |
| 86 | positive regulation of synaptic transmission (GO:0050806) | 3.18441072 |
| 87 | regulation of neurotransmitter levels (GO:0001505) | 3.18006515 |
| 88 | behavioral defense response (GO:0002209) | 3.17654791 |
| 89 | behavioral fear response (GO:0001662) | 3.17654791 |
| 90 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.17226773 |
| 91 | learning (GO:0007612) | 3.17132791 |
| 92 | regulation of neurotransmitter transport (GO:0051588) | 3.15818718 |
| 93 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.15556775 |
| 94 | female mating behavior (GO:0060180) | 3.13749658 |
| 95 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.12229460 |
| 96 | fear response (GO:0042596) | 3.11299099 |
| 97 | * negative regulation of amino acid transport (GO:0051956) | 3.11221372 |
| 98 | auditory behavior (GO:0031223) | 3.10533328 |
| 99 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.09008878 |
| 100 | synaptic transmission, dopaminergic (GO:0001963) | 3.08698709 |
| 101 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.08352633 |
| 102 | neutral lipid catabolic process (GO:0046461) | 3.08246544 |
| 103 | acylglycerol catabolic process (GO:0046464) | 3.08246544 |
| 104 | membrane depolarization (GO:0051899) | 3.08181392 |
| 105 | valine metabolic process (GO:0006573) | 3.07762439 |
| 106 | membrane repolarization (GO:0086009) | 3.07497983 |
| 107 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.07113559 |
| 108 | regulation of synapse structural plasticity (GO:0051823) | 3.05499358 |
| 109 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.05116498 |
| 110 | detection of calcium ion (GO:0005513) | 3.04547087 |
| 111 | primary amino compound metabolic process (GO:1901160) | 3.03922120 |
| 112 | serotonin receptor signaling pathway (GO:0007210) | 3.02588099 |
| 113 | DNA damage response, detection of DNA damage (GO:0042769) | 2.99926341 |
| 114 | * regulation of synaptic transmission (GO:0050804) | 2.99816486 |
| 115 | regulation of protein kinase A signaling (GO:0010738) | 2.99293627 |
| 116 | * negative regulation of amine transport (GO:0051953) | 2.97069215 |
| 117 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.96701573 |
| 118 | striatum development (GO:0021756) | 2.96677905 |
| 119 | response to dietary excess (GO:0002021) | 2.96262945 |
| 120 | dendritic spine morphogenesis (GO:0060997) | 2.96121828 |
| 121 | * synaptic transmission (GO:0007268) | 2.95377119 |
| 122 | mechanosensory behavior (GO:0007638) | 2.94274375 |
| 123 | establishment of synaptic vesicle localization (GO:0097480) | 2.93840521 |
| 124 | synaptic vesicle transport (GO:0048489) | 2.93840521 |
| 125 | regulation of synapse assembly (GO:0051963) | 2.93571211 |
| 126 | synapse assembly (GO:0007416) | 2.93331794 |
| 127 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.93139231 |
| 128 | proline transport (GO:0015824) | 2.91888148 |
| 129 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.91451508 |
| 130 | neuronal ion channel clustering (GO:0045161) | 2.88342125 |
| 131 | potassium ion export (GO:0071435) | 2.87032511 |
| 132 | fatty acid homeostasis (GO:0055089) | 2.86568336 |
| 133 | protein localization to cilium (GO:0061512) | 2.86380911 |
| 134 | vascular smooth muscle contraction (GO:0014829) | 2.85336912 |
| 135 | transmission of nerve impulse (GO:0019226) | 2.78301977 |
| 136 | nerve growth factor signaling pathway (GO:0038180) | 2.77606882 |
| 137 | response to leptin (GO:0044321) | 2.75808376 |
| 138 | brain morphogenesis (GO:0048854) | 2.75283129 |
| 139 | cell wall macromolecule metabolic process (GO:0044036) | 2.74635749 |
| 140 | peroxisome fission (GO:0016559) | 2.73895446 |
| 141 | regulation of sequestering of triglyceride (GO:0010889) | 2.73525764 |
| 142 | retinal rod cell development (GO:0046548) | 2.73131738 |
| 143 | adrenergic receptor signaling pathway (GO:0071875) | 2.72721699 |
| 144 | positive regulation of male gonad development (GO:2000020) | 2.71871664 |
| 145 | limb bud formation (GO:0060174) | 2.71786272 |
| 146 | keratinocyte development (GO:0003334) | 2.71718092 |
| 147 | regulation of protein glycosylation (GO:0060049) | 2.68134929 |
| 148 | regulation of mitochondrial fission (GO:0090140) | 2.67668519 |
| 149 | nucleobase catabolic process (GO:0046113) | 2.64523480 |
| 150 | membrane repolarization during action potential (GO:0086011) | 2.62434862 |
| 151 | alpha-linolenic acid metabolic process (GO:0036109) | 2.60615846 |
| 152 | retinal ganglion cell axon guidance (GO:0031290) | 2.59704318 |
| 153 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 2.59160979 |
| 154 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.58234755 |
| 155 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.57684526 |
| 156 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.57648025 |
| 157 | regulation of helicase activity (GO:0051095) | 2.55168854 |
| 158 | parturition (GO:0007567) | 2.54375250 |
| 159 | adult feeding behavior (GO:0008343) | 2.53888493 |
| 160 | platelet dense granule organization (GO:0060155) | 2.52634771 |
| 161 | glucosamine-containing compound catabolic process (GO:1901072) | 2.49979353 |
| 162 | lipid particle organization (GO:0034389) | 2.48533382 |
| 163 | melanosome transport (GO:0032402) | 2.45710466 |
| 164 | cell communication involved in cardiac conduction (GO:0086065) | 2.45133000 |
| 165 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.44762593 |
| 166 | cGMP-mediated signaling (GO:0019934) | 2.43191051 |
| 167 | neuronal action potential (GO:0019228) | 2.41888291 |
| 168 | nonmotile primary cilium assembly (GO:0035058) | 2.41788198 |
| 169 | low-density lipoprotein particle clearance (GO:0034383) | 2.39553928 |
| 170 | dendrite morphogenesis (GO:0048813) | 2.37050844 |
| 171 | hindbrain development (GO:0030902) | 2.36683993 |
| 172 | cellular response to BMP stimulus (GO:0071773) | 2.36620644 |
| 173 | response to BMP (GO:0071772) | 2.36620644 |
| 174 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.36053020 |
| 175 | cardiac muscle cell action potential (GO:0086001) | 2.36044238 |
| 176 | regulation of response to food (GO:0032095) | 2.34986067 |
| 177 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.33541148 |
| 178 | kidney morphogenesis (GO:0060993) | 2.32949369 |
| 179 | establishment of melanosome localization (GO:0032401) | 2.31909917 |
| 180 | glycerol metabolic process (GO:0006071) | 2.31879842 |
| 181 | reflex (GO:0060004) | 2.31813764 |
| 182 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.31583751 |
| 183 | action potential (GO:0001508) | 2.31451952 |
| 184 | male meiosis I (GO:0007141) | 2.31378767 |
| 185 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.31221541 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.59754805 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.65341734 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.25198753 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.08597435 |
| 5 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.02869143 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.99465029 |
| 7 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.76999608 |
| 8 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.69586528 |
| 9 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.64049105 |
| 10 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.61155043 |
| 11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.54184448 |
| 12 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.54184448 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.53296035 |
| 14 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.52497768 |
| 15 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.49497936 |
| 16 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.48617565 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.41917668 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.40232298 |
| 19 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.38754599 |
| 20 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.38663266 |
| 21 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.35225650 |
| 22 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.33249329 |
| 23 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.29882353 |
| 24 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.27910725 |
| 25 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.24117859 |
| 26 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.09858142 |
| 27 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.09467894 |
| 28 | VDR_22108803_ChIP-Seq_LS180_Human | 2.03070719 |
| 29 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.99252018 |
| 30 | P300_19829295_ChIP-Seq_ESCs_Human | 1.99154049 |
| 31 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.98958159 |
| 32 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.98420862 |
| 33 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.90587497 |
| 34 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.85483069 |
| 35 | FUS_26573619_Chip-Seq_HEK293_Human | 1.82384367 |
| 36 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.81487616 |
| 37 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.73165862 |
| 38 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.72946723 |
| 39 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.71924183 |
| 40 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.66336095 |
| 41 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.66067015 |
| 42 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.65970425 |
| 43 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.65445518 |
| 44 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.63492593 |
| 45 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.59564860 |
| 46 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.54661834 |
| 47 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.53500081 |
| 48 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.51369552 |
| 49 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.50811706 |
| 50 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.50373321 |
| 51 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.49891384 |
| 52 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.49067583 |
| 53 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.46537026 |
| 54 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.46157346 |
| 55 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.45620254 |
| 56 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.45418718 |
| 57 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.43455135 |
| 58 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.43201742 |
| 59 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.43201742 |
| 60 | AR_25329375_ChIP-Seq_VCAP_Human | 1.42719010 |
| 61 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.42463462 |
| 62 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.41308627 |
| 63 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.40733888 |
| 64 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.35756032 |
| 65 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.35720750 |
| 66 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.35272340 |
| 67 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.31811142 |
| 68 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.31756151 |
| 69 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.31681478 |
| 70 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.30226731 |
| 71 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.30067046 |
| 72 | JUN_21703547_ChIP-Seq_K562_Human | 1.29548287 |
| 73 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.28860850 |
| 74 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.28130961 |
| 75 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.27616946 |
| 76 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.27266399 |
| 77 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.26017825 |
| 78 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.25404050 |
| 79 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.22824882 |
| 80 | STAT3_23295773_ChIP-Seq_U87_Human | 1.20906020 |
| 81 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.17986757 |
| 82 | TCF4_23295773_ChIP-Seq_U87_Human | 1.17215683 |
| 83 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.15881303 |
| 84 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.15736972 |
| 85 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.15160574 |
| 86 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.14705110 |
| 87 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.14583879 |
| 88 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.13785060 |
| 89 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.12081032 |
| 90 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.11502170 |
| 91 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.11439240 |
| 92 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.11050343 |
| 93 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.09695743 |
| 94 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.08703881 |
| 95 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.08697951 |
| 96 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.08654619 |
| 97 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.07423565 |
| 98 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.06624382 |
| 99 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.05483043 |
| 100 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04649744 |
| 101 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.04645801 |
| 102 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.03727451 |
| 103 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.03717288 |
| 104 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.02477789 |
| 105 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.02079086 |
| 106 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.00979135 |
| 107 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.00025810 |
| 108 | AR_19668381_ChIP-Seq_PC3_Human | 0.99550714 |
| 109 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.99448467 |
| 110 | EWS_26573619_Chip-Seq_HEK293_Human | 0.99326115 |
| 111 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.99290509 |
| 112 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.99219702 |
| 113 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.99004701 |
| 114 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.97862803 |
| 115 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.97222413 |
| 116 | KDM2B_26808549_Chip-Seq_REH_Human | 0.95821034 |
| 117 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.94824144 |
| 118 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93739694 |
| 119 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.93244393 |
| 120 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.92116113 |
| 121 | TP53_16413492_ChIP-PET_HCT116_Human | 0.91768710 |
| 122 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90866715 |
| 123 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.90784778 |
| 124 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.89950689 |
| 125 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.89168209 |
| 126 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.88416024 |
| 127 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.88229297 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 5.94700733 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 5.39256395 |
| 3 | MP0005670_abnormal_white_adipose | 4.63114414 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.98276019 |
| 5 | MP0009745_abnormal_behavioral_response | 3.66004636 |
| 6 | MP0001968_abnormal_touch/_nociception | 3.59360674 |
| 7 | MP0002822_catalepsy | 3.50571983 |
| 8 | MP0002064_seizures | 3.25260422 |
| 9 | MP0002063_abnormal_learning/memory/cond | 3.25101883 |
| 10 | MP0009046_muscle_twitch | 3.16188216 |
| 11 | MP0004270_analgesia | 3.01634012 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.92450080 |
| 13 | MP0002736_abnormal_nociception_after | 2.80456420 |
| 14 | MP0005666_abnormal_adipose_tissue | 2.80063822 |
| 15 | MP0002272_abnormal_nervous_system | 2.56780293 |
| 16 | MP0003136_yellow_coat_color | 2.53906880 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.48996724 |
| 18 | MP0002735_abnormal_chemical_nociception | 2.42373806 |
| 19 | MP0002837_dystrophic_cardiac_calcinosis | 2.36290011 |
| 20 | MP0003890_abnormal_embryonic-extraembry | 2.34708963 |
| 21 | MP0001188_hyperpigmentation | 2.34261620 |
| 22 | MP0001440_abnormal_grooming_behavior | 2.28392379 |
| 23 | MP0004185_abnormal_adipocyte_glucose | 2.26242152 |
| 24 | MP0002734_abnormal_mechanical_nocicepti | 2.25740865 |
| 25 | MP0001486_abnormal_startle_reflex | 2.18448040 |
| 26 | MP0003122_maternal_imprinting | 2.13873915 |
| 27 | MP0005248_abnormal_Harderian_gland | 2.12442844 |
| 28 | MP0006276_abnormal_autonomic_nervous | 2.11683011 |
| 29 | MP0002067_abnormal_sensory_capabilities | 2.10977909 |
| 30 | MP0009780_abnormal_chondrocyte_physiolo | 2.05412372 |
| 31 | MP0003787_abnormal_imprinting | 1.98383325 |
| 32 | MP0001905_abnormal_dopamine_level | 1.93689351 |
| 33 | MP0002733_abnormal_thermal_nociception | 1.91641224 |
| 34 | MP0004924_abnormal_behavior | 1.84333613 |
| 35 | MP0005386_behavior/neurological_phenoty | 1.84333613 |
| 36 | MP0004130_abnormal_muscle_cell | 1.81270866 |
| 37 | MP0001529_abnormal_vocalization | 1.81183323 |
| 38 | MP0003879_abnormal_hair_cell | 1.75947189 |
| 39 | MP0001970_abnormal_pain_threshold | 1.75479307 |
| 40 | MP0002557_abnormal_social/conspecific_i | 1.69785125 |
| 41 | MP0008789_abnormal_olfactory_epithelium | 1.69431357 |
| 42 | MP0002184_abnormal_innervation | 1.69018224 |
| 43 | MP0001984_abnormal_olfaction | 1.68094154 |
| 44 | MP0000537_abnormal_urethra_morphology | 1.67003010 |
| 45 | MP0005423_abnormal_somatic_nervous | 1.65465329 |
| 46 | MP0004084_abnormal_cardiac_muscle | 1.65352861 |
| 47 | MP0005646_abnormal_pituitary_gland | 1.65147089 |
| 48 | MP0003329_amyloid_beta_deposits | 1.63116641 |
| 49 | MP0002653_abnormal_ependyma_morphology | 1.56946551 |
| 50 | MP0000778_abnormal_nervous_system | 1.53702103 |
| 51 | MP0005647_abnormal_sex_gland | 1.53547340 |
| 52 | MP0005645_abnormal_hypothalamus_physiol | 1.53379630 |
| 53 | MP0003011_delayed_dark_adaptation | 1.53301125 |
| 54 | MP0005375_adipose_tissue_phenotype | 1.52986979 |
| 55 | MP0003137_abnormal_impulse_conducting | 1.52866144 |
| 56 | MP0002876_abnormal_thyroid_physiology | 1.45232246 |
| 57 | MP0005167_abnormal_blood-brain_barrier | 1.43385016 |
| 58 | MP0002638_abnormal_pupillary_reflex | 1.42374373 |
| 59 | MP0002751_abnormal_autonomic_nervous | 1.41806207 |
| 60 | MP0004811_abnormal_neuron_physiology | 1.38952110 |
| 61 | MP0000013_abnormal_adipose_tissue | 1.38197404 |
| 62 | MP0002909_abnormal_adrenal_gland | 1.37637038 |
| 63 | MP0008569_lethality_at_weaning | 1.35868748 |
| 64 | MP0001502_abnormal_circadian_rhythm | 1.35686257 |
| 65 | MP0009672_abnormal_birth_weight | 1.35641481 |
| 66 | MP0003119_abnormal_digestive_system | 1.34830828 |
| 67 | MP0004142_abnormal_muscle_tone | 1.33827678 |
| 68 | MP0002066_abnormal_motor_capabilities/c | 1.32639290 |
| 69 | MP0010386_abnormal_urinary_bladder | 1.28099862 |
| 70 | MP0006292_abnormal_olfactory_placode | 1.22585507 |
| 71 | MP0003959_abnormal_lean_body | 1.22297599 |
| 72 | MP0002971_abnormal_brown_adipose | 1.19283708 |
| 73 | MP0003633_abnormal_nervous_system | 1.18136057 |
| 74 | MP0000955_abnormal_spinal_cord | 1.16387501 |
| 75 | MP0002882_abnormal_neuron_morphology | 1.16366994 |
| 76 | MP0003941_abnormal_skin_development | 1.16129899 |
| 77 | MP0002254_reproductive_system_inflammat | 1.15195660 |
| 78 | MP0005171_absent_coat_pigmentation | 1.11980622 |
| 79 | MP0001661_extended_life_span | 1.10024957 |
| 80 | MP0005503_abnormal_tendon_morphology | 1.07273571 |
| 81 | * MP0005334_abnormal_fat_pad | 1.06870938 |
| 82 | MP0003221_abnormal_cardiomyocyte_apopto | 1.05052639 |
| 83 | MP0003631_nervous_system_phenotype | 1.04058659 |
| 84 | MP0000751_myopathy | 1.03155405 |
| 85 | MP0001346_abnormal_lacrimal_gland | 1.02470665 |
| 86 | MP0004742_abnormal_vestibular_system | 1.01180206 |
| 87 | MP0004858_abnormal_nervous_system | 1.00419083 |
| 88 | MP0008872_abnormal_physiological_respon | 0.97762028 |
| 89 | MP0005253_abnormal_eye_physiology | 0.97167398 |
| 90 | MP0009703_decreased_birth_body | 0.96966714 |
| 91 | MP0003937_abnormal_limbs/digits/tail_de | 0.96890974 |
| 92 | MP0003121_genomic_imprinting | 0.96527597 |
| 93 | MP0005409_darkened_coat_color | 0.94155638 |
| 94 | MP0002160_abnormal_reproductive_system | 0.94087045 |
| 95 | MP0006138_congestive_heart_failure | 0.92746024 |
| 96 | MP0008874_decreased_physiological_sensi | 0.92321840 |
| 97 | MP0005535_abnormal_body_temperature | 0.90390294 |
| 98 | MP0001764_abnormal_homeostasis | 0.90091839 |
| 99 | MP0001963_abnormal_hearing_physiology | 0.89636793 |
| 100 | * MP0002069_abnormal_eating/drinking_beha | 0.89388727 |
| 101 | MP0005367_renal/urinary_system_phenotyp | 0.88994125 |
| 102 | MP0000516_abnormal_urinary_system | 0.88994125 |
| 103 | MP0005620_abnormal_muscle_contractility | 0.88611012 |
| 104 | MP0005551_abnormal_eye_electrophysiolog | 0.88339597 |
| 105 | MP0008877_abnormal_DNA_methylation | 0.87802836 |
| 106 | MP0004484_altered_response_of | 0.86438270 |
| 107 | MP0002152_abnormal_brain_morphology | 0.85686917 |
| 108 | MP0001879_abnormal_lymphatic_vessel | 0.84506225 |
| 109 | MP0004147_increased_porphyrin_level | 0.83952165 |
| 110 | MP0005195_abnormal_posterior_eye | 0.83910870 |
| 111 | MP0004085_abnormal_heartbeat | 0.83222986 |
| 112 | MP0003718_maternal_effect | 0.82404749 |
| 113 | MP0002229_neurodegeneration | 0.82192002 |
| 114 | MP0001664_abnormal_digestion | 0.81075517 |
| 115 | MP0000427_abnormal_hair_cycle | 0.80622354 |
| 116 | MP0006072_abnormal_retinal_apoptosis | 0.80089385 |
| 117 | MP0003315_abnormal_perineum_morphology | 0.80079678 |
| 118 | MP0004885_abnormal_endolymph | 0.79760076 |
| 119 | MP0003861_abnormal_nervous_system | 0.78131342 |
| 120 | MP0004145_abnormal_muscle_electrophysio | 0.77407892 |
| 121 | MP0002697_abnormal_eye_size | 0.76801597 |
| 122 | MP0000604_amyloidosis | 0.76229736 |
| 123 | MP0003183_abnormal_peptide_metabolism | 0.75383553 |
| 124 | MP0003123_paternal_imprinting | 0.75207733 |
| 125 | MP0004215_abnormal_myocardial_fiber | 0.73600410 |
| 126 | MP0000631_abnormal_neuroendocrine_gland | 0.71844725 |
| 127 | MP0001177_atelectasis | 0.67888777 |
| 128 | MP0003632_abnormal_nervous_system | 0.67310219 |
| 129 | MP0005379_endocrine/exocrine_gland_phen | 0.64205663 |
| 130 | MP0002752_abnormal_somatic_nervous | 0.63454258 |
| 131 | MP0001943_abnormal_respiration | 0.60475026 |
| 132 | MP0008004_abnormal_stomach_pH | 0.59379219 |
| 133 | MP0004233_abnormal_muscle_weight | 0.58877125 |
| 134 | MP0005623_abnormal_meninges_morphology | 0.56972533 |
| 135 | MP0002163_abnormal_gland_morphology | 0.56594320 |
| 136 | MP0001485_abnormal_pinna_reflex | 0.56558322 |
| 137 | MP0002090_abnormal_vision | 0.56540899 |
| 138 | MP0004036_abnormal_muscle_relaxation | 0.55744493 |
| 139 | MP0000026_abnormal_inner_ear | 0.54563659 |
| 140 | MP0005187_abnormal_penis_morphology | 0.53660414 |
| 141 | MP0010234_abnormal_vibrissa_follicle | 0.49345479 |
| 142 | MP0002082_postnatal_lethality | 0.48861383 |
| 143 | MP0010770_preweaning_lethality | 0.48861383 |
| 144 | MP0001765_abnormal_ion_homeostasis | 0.48456945 |
| 145 | MP0003283_abnormal_digestive_organ | 0.47876409 |
| 146 | MP0003646_muscle_fatigue | 0.47870767 |
| 147 | * MP0005448_abnormal_energy_balance | 0.46660362 |
| 148 | MP0005499_abnormal_olfactory_system | 0.45886151 |
| 149 | MP0005394_taste/olfaction_phenotype | 0.45886151 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.43812966 |
| 2 | Hyperventilation (HP:0002883) | 6.36704450 |
| 3 | Epileptic encephalopathy (HP:0200134) | 6.35186371 |
| 4 | Atonic seizures (HP:0010819) | 5.79253506 |
| 5 | Focal seizures (HP:0007359) | 5.49395730 |
| 6 | Febrile seizures (HP:0002373) | 5.02450919 |
| 7 | Myokymia (HP:0002411) | 4.79463995 |
| 8 | Absence seizures (HP:0002121) | 4.71384664 |
| 9 | Dialeptic seizures (HP:0011146) | 4.65301204 |
| 10 | Visual hallucinations (HP:0002367) | 4.31378601 |
| 11 | Broad-based gait (HP:0002136) | 4.09661751 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 3.88421577 |
| 13 | Amblyopia (HP:0000646) | 3.65664095 |
| 14 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.48712560 |
| 15 | Colon cancer (HP:0003003) | 3.45991913 |
| 16 | Chromsome breakage (HP:0040012) | 3.37085211 |
| 17 | Intestinal atresia (HP:0011100) | 3.26439100 |
| 18 | Progressive inability to walk (HP:0002505) | 3.19989617 |
| 19 | Progressive cerebellar ataxia (HP:0002073) | 3.19010848 |
| 20 | Abnormal eating behavior (HP:0100738) | 3.18278266 |
| 21 | Protruding tongue (HP:0010808) | 3.13504321 |
| 22 | Drooling (HP:0002307) | 3.12889463 |
| 23 | Excessive salivation (HP:0003781) | 3.12889463 |
| 24 | Congenital primary aphakia (HP:0007707) | 3.09041325 |
| 25 | Epileptiform EEG discharges (HP:0011182) | 3.07696284 |
| 26 | Inability to walk (HP:0002540) | 3.07109715 |
| 27 | Poor eye contact (HP:0000817) | 3.04818622 |
| 28 | Acute necrotizing encephalopathy (HP:0006965) | 3.00714073 |
| 29 | Dysdiadochokinesis (HP:0002075) | 2.95828205 |
| 30 | Polyphagia (HP:0002591) | 2.92290346 |
| 31 | Anxiety (HP:0000739) | 2.89226974 |
| 32 | Thickened helices (HP:0000391) | 2.88927651 |
| 33 | Medial flaring of the eyebrow (HP:0010747) | 2.88739969 |
| 34 | Vaginal atresia (HP:0000148) | 2.88133017 |
| 35 | Genital tract atresia (HP:0001827) | 2.83866468 |
| 36 | Nephrogenic diabetes insipidus (HP:0009806) | 2.83509856 |
| 37 | Abnormal hair whorl (HP:0010721) | 2.82848971 |
| 38 | Abnormal sex determination (HP:0012244) | 2.81447719 |
| 39 | Sex reversal (HP:0012245) | 2.81447719 |
| 40 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.81318386 |
| 41 | Renal cortical cysts (HP:0000803) | 2.76332710 |
| 42 | Gaze-evoked nystagmus (HP:0000640) | 2.73923917 |
| 43 | Truncal ataxia (HP:0002078) | 2.73778818 |
| 44 | Progressive macrocephaly (HP:0004481) | 2.71181333 |
| 45 | Impaired social interactions (HP:0000735) | 2.66948442 |
| 46 | Abnormal social behavior (HP:0012433) | 2.66948442 |
| 47 | Vitreoretinal degeneration (HP:0000655) | 2.64198145 |
| 48 | Poor coordination (HP:0002370) | 2.63288742 |
| 49 | Hyperthyroidism (HP:0000836) | 2.63091782 |
| 50 | Embryonal renal neoplasm (HP:0011794) | 2.62635149 |
| 51 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.61490538 |
| 52 | Pheochromocytoma (HP:0002666) | 2.60209613 |
| 53 | EEG with generalized epileptiform discharges (HP:0011198) | 2.59351018 |
| 54 | True hermaphroditism (HP:0010459) | 2.55417043 |
| 55 | Cerebral inclusion bodies (HP:0100314) | 2.54561572 |
| 56 | Mitochondrial inheritance (HP:0001427) | 2.48977658 |
| 57 | Neuroendocrine neoplasm (HP:0100634) | 2.48391552 |
| 58 | Septo-optic dysplasia (HP:0100842) | 2.48269634 |
| 59 | Ankle clonus (HP:0011448) | 2.44556940 |
| 60 | Hepatoblastoma (HP:0002884) | 2.43607745 |
| 61 | Poor suck (HP:0002033) | 2.43524739 |
| 62 | Dysmetria (HP:0001310) | 2.42460378 |
| 63 | Supranuclear gaze palsy (HP:0000605) | 2.42244411 |
| 64 | Absent speech (HP:0001344) | 2.39242062 |
| 65 | Acute encephalopathy (HP:0006846) | 2.38864720 |
| 66 | Urinary urgency (HP:0000012) | 2.35687388 |
| 67 | Scrotal hypoplasia (HP:0000046) | 2.33429070 |
| 68 | Hypsarrhythmia (HP:0002521) | 2.32518008 |
| 69 | Depression (HP:0000716) | 2.32161401 |
| 70 | Termporal pattern (HP:0011008) | 2.30974655 |
| 71 | Insidious onset (HP:0003587) | 2.30974655 |
| 72 | Failure to thrive in infancy (HP:0001531) | 2.29571100 |
| 73 | Abnormality of the labia minora (HP:0012880) | 2.29209026 |
| 74 | Absent eyebrow (HP:0002223) | 2.28910596 |
| 75 | Bradykinesia (HP:0002067) | 2.27933503 |
| 76 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.27695880 |
| 77 | Blue irides (HP:0000635) | 2.27582658 |
| 78 | Sensory axonal neuropathy (HP:0003390) | 2.27199565 |
| 79 | Status epilepticus (HP:0002133) | 2.25024725 |
| 80 | Rectovaginal fistula (HP:0000143) | 2.23521675 |
| 81 | Rectal fistula (HP:0100590) | 2.23521675 |
| 82 | Oligomenorrhea (HP:0000876) | 2.23311972 |
| 83 | Optic nerve hypoplasia (HP:0000609) | 2.23121542 |
| 84 | Abnormality of the ileum (HP:0001549) | 2.21740888 |
| 85 | Abnormal ciliary motility (HP:0012262) | 2.21185744 |
| 86 | Retinal atrophy (HP:0001105) | 2.21021512 |
| 87 | Limb dystonia (HP:0002451) | 2.20130633 |
| 88 | Subaortic stenosis (HP:0001682) | 2.17179207 |
| 89 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.17179207 |
| 90 | Generalized myoclonic seizures (HP:0002123) | 2.15868133 |
| 91 | Hypoglycemic coma (HP:0001325) | 2.15595442 |
| 92 | Retinal dysplasia (HP:0007973) | 2.14914530 |
| 93 | Astigmatism (HP:0000483) | 2.14803544 |
| 94 | Abolished electroretinogram (ERG) (HP:0000550) | 2.14602126 |
| 95 | Broad foot (HP:0001769) | 2.14430231 |
| 96 | Abnormality of salivation (HP:0100755) | 2.14098602 |
| 97 | Meckel diverticulum (HP:0002245) | 2.13722690 |
| 98 | Increased CSF lactate (HP:0002490) | 2.13017006 |
| 99 | Action tremor (HP:0002345) | 2.12357354 |
| 100 | Esotropia (HP:0000565) | 2.11957791 |
| 101 | Prolonged QT interval (HP:0001657) | 2.11870971 |
| 102 | Delusions (HP:0000746) | 2.11792707 |
| 103 | Rimmed vacuoles (HP:0003805) | 2.10889647 |
| 104 | Syncope (HP:0001279) | 2.09118601 |
| 105 | Postural instability (HP:0002172) | 2.08425308 |
| 106 | Medulloblastoma (HP:0002885) | 2.07967586 |
| 107 | Abnormal gallbladder physiology (HP:0012438) | 2.06509584 |
| 108 | Cholecystitis (HP:0001082) | 2.06509584 |
| 109 | Stereotypic behavior (HP:0000733) | 2.06325292 |
| 110 | Psychosis (HP:0000709) | 2.04628950 |
| 111 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.04363108 |
| 112 | Hepatocellular necrosis (HP:0001404) | 2.03099538 |
| 113 | Hypoventilation (HP:0002791) | 2.02683189 |
| 114 | Narrow nasal bridge (HP:0000446) | 2.01290166 |
| 115 | Hyperglycinuria (HP:0003108) | 1.99559060 |
| 116 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.97758377 |
| 117 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.97758377 |
| 118 | Vaginal fistula (HP:0004320) | 1.97628663 |
| 119 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.97111719 |
| 120 | Volvulus (HP:0002580) | 1.96207408 |
| 121 | Incomplete penetrance (HP:0003829) | 1.95053896 |
| 122 | Impaired smooth pursuit (HP:0007772) | 1.94385403 |
| 123 | Fair hair (HP:0002286) | 1.93973441 |
| 124 | Gait imbalance (HP:0002141) | 1.93477285 |
| 125 | Pendular nystagmus (HP:0012043) | 1.92833075 |
| 126 | Hemiparesis (HP:0001269) | 1.92610372 |
| 127 | Gait ataxia (HP:0002066) | 1.92139876 |
| 128 | Optic disc pallor (HP:0000543) | 1.91767073 |
| 129 | Dysmetric saccades (HP:0000641) | 1.91584627 |
| 130 | Menstrual irregularities (HP:0000858) | 1.90878885 |
| 131 | Resting tremor (HP:0002322) | 1.89694202 |
| 132 | Cerebral edema (HP:0002181) | 1.88508740 |
| 133 | Gastroesophageal reflux (HP:0002020) | 1.88194050 |
| 134 | Nausea (HP:0002018) | 1.86449602 |
| 135 | Abnormality of the columella (HP:0009929) | 1.85916871 |
| 136 | Epidermoid cyst (HP:0200040) | 1.85235758 |
| 137 | Torticollis (HP:0000473) | 1.84457537 |
| 138 | Fetal akinesia sequence (HP:0001989) | 1.83240240 |
| 139 | Cupped ear (HP:0000378) | 1.83182878 |
| 140 | Hypothermia (HP:0002045) | 1.82743797 |
| 141 | Abnormality of alanine metabolism (HP:0010916) | 1.82684077 |
| 142 | Hyperalaninemia (HP:0003348) | 1.82684077 |
| 143 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.82684077 |
| 144 | Ventricular fibrillation (HP:0001663) | 1.80367396 |
| 145 | Intestinal fistula (HP:0100819) | 1.79806691 |
| 146 | Diplopia (HP:0000651) | 1.78771461 |
| 147 | Abnormality of binocular vision (HP:0011514) | 1.78771461 |
| 148 | Generalized hypopigmentation of hair (HP:0011358) | 1.78660327 |
| 149 | Clonus (HP:0002169) | 1.78636268 |
| 150 | Lower limb asymmetry (HP:0100559) | 1.78307004 |
| 151 | Type II lissencephaly (HP:0007260) | 1.78089610 |
| 152 | Gastrointestinal atresia (HP:0002589) | 1.77827052 |
| 153 | Focal dystonia (HP:0004373) | 1.77320382 |
| 154 | Severe Myopia (HP:0011003) | 1.76076288 |
| 155 | Exotropia (HP:0000577) | 1.75647733 |
| 156 | Sparse lateral eyebrow (HP:0005338) | 1.75265495 |
| 157 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.75139992 |
| 158 | Choanal stenosis (HP:0000452) | 1.71650874 |
| 159 | Unilateral renal agenesis (HP:0000122) | 1.70958920 |
| 160 | Renal hypoplasia (HP:0000089) | 1.70451879 |
| 161 | Abnormal protein glycosylation (HP:0012346) | 1.70319134 |
| 162 | Abnormal glycosylation (HP:0012345) | 1.70319134 |
| 163 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.70319134 |
| 164 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.70319134 |
| 165 | Adactyly (HP:0009776) | 1.70293503 |
| 166 | Genetic anticipation (HP:0003743) | 1.68582964 |
| 167 | Abnormality of chromosome stability (HP:0003220) | 1.67446869 |
| 168 | Back pain (HP:0003418) | 1.67444667 |
| 169 | Postnatal microcephaly (HP:0005484) | 1.66857104 |
| 170 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.65229912 |
| 171 | Maternal diabetes (HP:0009800) | 1.62625326 |
| 172 | Triphalangeal thumb (HP:0001199) | 1.60178018 |
| 173 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.59266012 |
| 174 | Abnormality of glycine metabolism (HP:0010895) | 1.59266012 |
| 175 | Neoplasm of the adrenal cortex (HP:0100641) | 1.58989988 |
| 176 | Partial duplication of the phalanx of hand (HP:0009999) | 1.58901345 |
| 177 | Ulnar claw (HP:0001178) | 1.58432944 |
| 178 | Chorioretinal atrophy (HP:0000533) | 1.57849343 |
| 179 | Cerebellar dysplasia (HP:0007033) | 1.55114032 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 5.79664324 |
| 2 | EPHA4 | 4.14235513 |
| 3 | WNK3 | 4.12808114 |
| 4 | NTRK3 | 3.94817563 |
| 5 | MAP3K12 | 3.34859887 |
| 6 | MAP3K4 | 3.03000285 |
| 7 | MAP2K7 | 2.97106448 |
| 8 | MAP3K9 | 2.78141015 |
| 9 | RIPK4 | 2.44087032 |
| 10 | MINK1 | 2.37604939 |
| 11 | DAPK2 | 2.36899633 |
| 12 | PLK2 | 2.35190551 |
| 13 | LATS1 | 2.32471008 |
| 14 | TRIM28 | 2.24627322 |
| 15 | AKT3 | 2.23206119 |
| 16 | DYRK2 | 2.22489372 |
| 17 | CDK19 | 2.20523152 |
| 18 | NME1 | 2.16100516 |
| 19 | DAPK1 | 2.12060495 |
| 20 | MAP2K4 | 2.06046179 |
| 21 | CCNB1 | 1.97841674 |
| 22 | STK38L | 1.92780270 |
| 23 | TIE1 | 1.92599899 |
| 24 | MKNK2 | 1.85161729 |
| 25 | ARAF | 1.82423944 |
| 26 | NUAK1 | 1.73922329 |
| 27 | PNCK | 1.70115069 |
| 28 | MARK1 | 1.70097083 |
| 29 | SIK3 | 1.66987013 |
| 30 | PLK4 | 1.66010288 |
| 31 | GRK5 | 1.64458630 |
| 32 | MKNK1 | 1.59630845 |
| 33 | LIMK1 | 1.58595329 |
| 34 | PKN1 | 1.58369793 |
| 35 | EPHB2 | 1.56161460 |
| 36 | TESK1 | 1.55568174 |
| 37 | FRK | 1.53959945 |
| 38 | KSR1 | 1.51402906 |
| 39 | BMPR2 | 1.48765328 |
| 40 | CAMK4 | 1.45308370 |
| 41 | NTRK2 | 1.38635993 |
| 42 | VRK2 | 1.37012857 |
| 43 | CSNK1G3 | 1.34823111 |
| 44 | OXSR1 | 1.34239400 |
| 45 | KSR2 | 1.30448966 |
| 46 | PKN2 | 1.29581786 |
| 47 | TNIK | 1.29113962 |
| 48 | PTK2B | 1.29111366 |
| 49 | BRSK2 | 1.29017831 |
| 50 | PRPF4B | 1.28516534 |
| 51 | BMPR1B | 1.25193421 |
| 52 | KDR | 1.24689500 |
| 53 | CSNK1G1 | 1.24202217 |
| 54 | CSNK1A1L | 1.21631623 |
| 55 | CDK5 | 1.20579419 |
| 56 | PAK6 | 1.19763179 |
| 57 | CAMK2A | 1.17809534 |
| 58 | CAMKK2 | 1.13278915 |
| 59 | FES | 1.12672302 |
| 60 | ERBB3 | 1.12086484 |
| 61 | CAMK1D | 1.09260718 |
| 62 | VRK1 | 1.08289546 |
| 63 | BRAF | 1.08255524 |
| 64 | MAP3K13 | 1.07138599 |
| 65 | MUSK | 1.06892308 |
| 66 | PRKCG | 1.06495772 |
| 67 | CAMK2B | 1.03676744 |
| 68 | BCR | 1.01623043 |
| 69 | SIK2 | 0.97389823 |
| 70 | FGR | 0.94039780 |
| 71 | NTRK1 | 0.92700982 |
| 72 | NLK | 0.91569672 |
| 73 | PDK3 | 0.90672371 |
| 74 | PDK4 | 0.90672371 |
| 75 | INSRR | 0.89491159 |
| 76 | TGFBR2 | 0.88136705 |
| 77 | OBSCN | 0.84978440 |
| 78 | CAMKK1 | 0.84639882 |
| 79 | MAPK13 | 0.84593436 |
| 80 | MAP4K2 | 0.81802963 |
| 81 | MAP3K5 | 0.81104138 |
| 82 | DYRK3 | 0.81015695 |
| 83 | RAF1 | 0.79041256 |
| 84 | YES1 | 0.78491536 |
| 85 | GRK6 | 0.77821975 |
| 86 | PRKAA2 | 0.77500492 |
| 87 | CDK18 | 0.76162921 |
| 88 | SGK494 | 0.73286845 |
| 89 | SGK223 | 0.73286845 |
| 90 | MAP3K7 | 0.71562198 |
| 91 | PBK | 0.71129775 |
| 92 | PRKACB | 0.70715077 |
| 93 | CDK14 | 0.69101985 |
| 94 | TSSK6 | 0.68103593 |
| 95 | SGK2 | 0.66729097 |
| 96 | CDK15 | 0.66063291 |
| 97 | GRK7 | 0.66012890 |
| 98 | PRKCE | 0.65755529 |
| 99 | TGFBR1 | 0.65331706 |
| 100 | FER | 0.65004899 |
| 101 | ADRBK1 | 0.64566971 |
| 102 | ROCK1 | 0.63124032 |
| 103 | STK11 | 0.61251725 |
| 104 | UHMK1 | 0.61238151 |
| 105 | ADRBK2 | 0.59573297 |
| 106 | CSNK1E | 0.57738519 |
| 107 | CAMK1 | 0.57219826 |
| 108 | IRAK2 | 0.56371912 |
| 109 | CAMK1G | 0.56340101 |
| 110 | ZAK | 0.55928839 |
| 111 | CDK11A | 0.55227752 |
| 112 | STK3 | 0.54001377 |
| 113 | MAPK4 | 0.53748219 |
| 114 | GRK1 | 0.52524137 |
| 115 | MYLK | 0.51847358 |
| 116 | DAPK3 | 0.51743441 |
| 117 | LATS2 | 0.51533253 |
| 118 | FLT3 | 0.49131627 |
| 119 | NEK1 | 0.48708639 |
| 120 | MAP3K2 | 0.46886372 |
| 121 | SGK1 | 0.46249042 |
| 122 | CAMK2D | 0.46106637 |
| 123 | PRKG1 | 0.43109304 |
| 124 | FGFR1 | 0.42302686 |
| 125 | TYRO3 | 0.42204208 |
| 126 | PRKDC | 0.42071887 |
| 127 | DYRK1A | 0.41743443 |
| 128 | CAMK2G | 0.41578660 |
| 129 | PAK3 | 0.41486878 |
| 130 | FGFR2 | 0.41295671 |
| 131 | CDK3 | 0.40974464 |
| 132 | STK38 | 0.40613380 |
| 133 | MAP3K6 | 0.40487083 |
| 134 | PDPK1 | 0.40277456 |
| 135 | MAPK7 | 0.39698291 |
| 136 | PRKACA | 0.39597221 |
| 137 | PRKD3 | 0.39566573 |
| 138 | PRKACG | 0.39370769 |
| 139 | PASK | 0.38475104 |
| 140 | ROCK2 | 0.38395340 |
| 141 | PDK2 | 0.37156845 |
| 142 | PLK1 | 0.36427687 |
| 143 | MAP2K1 | 0.36417575 |
| 144 | SGK3 | 0.35633117 |
| 145 | MAP3K1 | 0.33675941 |
| 146 | CSNK1G2 | 0.33337551 |
| 147 | PRKCZ | 0.33037563 |
| 148 | PDK1 | 0.31576100 |
| 149 | PLK3 | 0.31099927 |
| 150 | PHKG2 | 0.30819358 |
| 151 | PHKG1 | 0.30819358 |
| 152 | STK39 | 0.30814113 |
| 153 | FYN | 0.29971165 |
| 154 | PINK1 | 0.29458317 |
| 155 | MAPK12 | 0.28787803 |
| 156 | PRKCH | 0.28107957 |
| 157 | RPS6KA3 | 0.27837661 |
| 158 | RET | 0.27364924 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.51224566 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.86295677 |
| 3 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.34873401 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.99371030 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.96178908 |
| 6 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.69924162 |
| 7 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.69745850 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.69572135 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.67957738 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.62519962 |
| 11 | Circadian entrainment_Homo sapiens_hsa04713 | 2.57112381 |
| 12 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.51298619 |
| 13 | Olfactory transduction_Homo sapiens_hsa04740 | 2.39130954 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.31086941 |
| 15 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.27236615 |
| 16 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.15574658 |
| 17 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.07803467 |
| 18 | Salivary secretion_Homo sapiens_hsa04970 | 2.02590769 |
| 19 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.99290708 |
| 20 | Taste transduction_Homo sapiens_hsa04742 | 1.96010529 |
| 21 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.95978741 |
| 22 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.89778807 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.82734185 |
| 24 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.77686543 |
| 25 | Long-term depression_Homo sapiens_hsa04730 | 1.77373654 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.76957966 |
| 27 | Alzheimers disease_Homo sapiens_hsa05010 | 1.75701079 |
| 28 | Parkinsons disease_Homo sapiens_hsa05012 | 1.70441964 |
| 29 | Insulin secretion_Homo sapiens_hsa04911 | 1.69812984 |
| 30 | Cocaine addiction_Homo sapiens_hsa05030 | 1.65776606 |
| 31 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.56134662 |
| 32 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.55995773 |
| 33 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.54620950 |
| 34 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.53839936 |
| 35 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.53716376 |
| 36 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.51153839 |
| 37 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.49628581 |
| 38 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.48748177 |
| 39 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.47856347 |
| 40 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.43188377 |
| 41 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.42368181 |
| 42 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.41326919 |
| 43 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.40452156 |
| 44 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.40360959 |
| 45 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.31386449 |
| 46 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.27855836 |
| 47 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.27265976 |
| 48 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.25080468 |
| 49 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.22892457 |
| 50 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.22260972 |
| 51 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.21588615 |
| 52 | Basal transcription factors_Homo sapiens_hsa03022 | 1.21122725 |
| 53 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.19290863 |
| 54 | RNA degradation_Homo sapiens_hsa03018 | 1.18049960 |
| 55 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.14064295 |
| 56 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.12801878 |
| 57 | Huntingtons disease_Homo sapiens_hsa05016 | 1.12619199 |
| 58 | Phototransduction_Homo sapiens_hsa04744 | 1.10706425 |
| 59 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.08204119 |
| 60 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.07575415 |
| 61 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.06331667 |
| 62 | Gap junction_Homo sapiens_hsa04540 | 1.06109398 |
| 63 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.05596094 |
| 64 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.04005914 |
| 65 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.01917968 |
| 66 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.00013464 |
| 67 | Tight junction_Homo sapiens_hsa04530 | 0.99496977 |
| 68 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.95309608 |
| 69 | Adherens junction_Homo sapiens_hsa04520 | 0.94809737 |
| 70 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.94693524 |
| 71 | Axon guidance_Homo sapiens_hsa04360 | 0.90353116 |
| 72 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.87988587 |
| 73 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.85783800 |
| 74 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.84792031 |
| 75 | Melanogenesis_Homo sapiens_hsa04916 | 0.84510205 |
| 76 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.84108479 |
| 77 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.82941548 |
| 78 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.82476198 |
| 79 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.82340605 |
| 80 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.81178261 |
| 81 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.81097241 |
| 82 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.80127443 |
| 83 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.80000450 |
| 84 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.78832267 |
| 85 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.76573935 |
| 86 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.76347542 |
| 87 | Retinol metabolism_Homo sapiens_hsa00830 | 0.75183597 |
| 88 | Glioma_Homo sapiens_hsa05214 | 0.75171129 |
| 89 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.74947665 |
| 90 | Mismatch repair_Homo sapiens_hsa03430 | 0.74009878 |
| 91 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.73045811 |
| 92 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.71969312 |
| 93 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.71023110 |
| 94 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.70029364 |
| 95 | Protein export_Homo sapiens_hsa03060 | 0.69713502 |
| 96 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.67479495 |
| 97 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.67118122 |
| 98 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.64902857 |
| 99 | Histidine metabolism_Homo sapiens_hsa00340 | 0.64521154 |
| 100 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.64278223 |
| 101 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.64061592 |
| 102 | Lysine degradation_Homo sapiens_hsa00310 | 0.61127740 |
| 103 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.60016054 |
| 104 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.59080338 |
| 105 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.58676048 |
| 106 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.58588867 |
| 107 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.58330312 |
| 108 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.57846188 |
| 109 | RNA transport_Homo sapiens_hsa03013 | 0.57583262 |
| 110 | Homologous recombination_Homo sapiens_hsa03440 | 0.57054427 |
| 111 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.56991949 |
| 112 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.56282383 |
| 113 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.56216233 |
| 114 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.54889338 |
| 115 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.54862108 |
| 116 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.53911222 |
| 117 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.52732294 |
| 118 | Phagosome_Homo sapiens_hsa04145 | 0.52189022 |
| 119 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.51499267 |
| 120 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.48107784 |
| 121 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.48011349 |
| 122 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.47671893 |
| 123 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.46947919 |
| 124 | Alcoholism_Homo sapiens_hsa05034 | 0.46605275 |
| 125 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.45972905 |
| 126 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.44304920 |
| 127 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.43076044 |
| 128 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.41535997 |
| 129 | Circadian rhythm_Homo sapiens_hsa04710 | 0.39041643 |
| 130 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.38100193 |
| 131 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.37714012 |
| 132 | Prion diseases_Homo sapiens_hsa05020 | 0.36208922 |
| 133 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.31827154 |
| 134 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.31479617 |
| 135 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.31469756 |
| 136 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.30217440 |
| 137 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.29956947 |
| 138 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.29712775 |
| 139 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.29252684 |
| 140 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.25300596 |
| 141 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.25207170 |
| 142 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.24240793 |
| 143 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.21743127 |
| 144 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.20957175 |
| 145 | Bile secretion_Homo sapiens_hsa04976 | 0.20866597 |
| 146 | Melanoma_Homo sapiens_hsa05218 | 0.19842903 |
| 147 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.18728995 |
| 148 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.17281982 |
| 149 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.17267228 |
| 150 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.17220314 |
| 151 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.16827249 |
| 152 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.15353092 |
| 153 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.13270990 |

